Bioasis Technologies Inc (BTI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bioasis Technologies Inc (BTI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7865
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across the blood brain barrier. It commercializes its business operations through Cognitest and Transcend names. BTI operates through research institutions and other biotechnology and pharmaceutical companies. The company provides services by conducting research and development with pharmaceutical companies and institutions to advance its technologies. BTI is headquartered in Richmond, British Columbia, Canada.

Bioasis Technologies Inc (BTI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bioasis Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bioasis Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bioasis Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bioasis Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Bioasis Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bioasis Technologies Inc, Medical Equipment, Deal Details 11
Equity Offering 11
Bioasis Raises USD0.7 Million in Private Placement of Shares 11
Bioasis Technologies Raises USD0.5 Million in Second Tranche of Private Placement of Units 12
biOasis Tech Raises USD3 Million in Private Placement of Units 14
Bioasis Tech Raises Funds through Private Placement of Units 15
biOasis Technologies Completes Private Placement Of Units For US$2.5 Million 16
Bioasis Technologies Inc – Key Competitors 17
Bioasis Technologies Inc – Key Employees 18
Bioasis Technologies Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jul 30, 2018: Bioasis Technologies announces financial results for three months ended May 31, 2018 20
Jun 26, 2018: Bioasis Technologies announces financial results for fiscal 2018 21
Jan 29, 2018: Bioasis Technologies announces financial results for three months ended November 30, 2017 22
Corporate Communications 23
Jul 27, 2018: Bioasis welcomes John E. Curran & David M. Wurzer to the company’s board of directors 23
Jun 12, 2018: Bioasis Technologies Dr. Mario Saltarelli, Dr. Jack Hoppin And Dr. Sue O Connor To Its Scientific Advisory Board 24
Mar 26, 2018: Bioasis Technologies Appoints Caroline Hill As senior vice president, Research & Development Operations 25
Mar 21, 2018: Bioasis Appoints Deborah Rathjen as Chair of the Board of Directors 26
Dec 04, 2017: Bioasis Implements Transition Plan for Its Board of Directors 27
Oct 02, 2017: biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor 28
Sep 21, 2017: BiOasis Announces Voting Results for 2017 Annual Meeting 29
Sep 18, 2017: biOasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member 30
Sep 07, 2017: biOasis Announces Formation of Scientific Advisory Board to Advance the Science for the Company’s Blood-Brain Barrier Drug Delivery Platform 32
Aug 28, 2017: biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders 34
Aug 21, 2017: biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer 36
Jun 25, 2017: biOasis Appoints Catherine London, Executive Vice President, Head of Corporate Communications and Investor Relations 37
Apr 24, 2017: biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director 38
Legal and Regulatory 39
May 14, 2018: Bioasis announces intention to pursue NASDAQ listing 39
Other Significant Developments 40
Jun 14, 2017: biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders 40
Mar 16, 2017: biOasis Announces the Engagement of Mackie Research to Provide Market Making Services 42
Jan 22, 2017: biOasis Provides AGM Update — Expanding The biOasis Deal Flow Pipeline 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Bioasis Technologies Inc, Medical Equipment, Key Facts, 2018 2
Bioasis Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bioasis Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bioasis Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bioasis Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bioasis Technologies Inc, Deals By Market, 2012 to YTD 2018 9
Bioasis Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bioasis Raises USD0.7 Million in Private Placement of Shares 11
Bioasis Technologies Raises USD0.5 Million in Second Tranche of Private Placement of Units 12
biOasis Tech Raises USD3 Million in Private Placement of Units 14
Bioasis Tech Raises Funds through Private Placement of Units 15
biOasis Technologies Completes Private Placement Of Units For US$2.5 Million 16
Bioasis Technologies Inc, Key Competitors 17
Bioasis Technologies Inc, Key Employees 18
Bioasis Technologies Inc, Other Locations 19
Bioasis Technologies Inc, Subsidiaries 19

List of Figures
Bioasis Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bioasis Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bioasis Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bioasis Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bioasis Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bioasis Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Bioasis Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bioasis Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Bioasis Technologies Inc (BTI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solvay Group:企業の戦略・SWOT・財務情報
    Solvay Group - Strategy, SWOT and Corporate Finance Report Summary Solvay Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Trovagene Inc (TROV)-医療機器分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Newfield Exploration Company (NFX)-石油・ガス分野:企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • Avgol Industries 1953 Ltd. (AVGL):企業の財務・戦略的SWOT分析
    Avgol Industries 1953 Ltd. (AVGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Natco Pharma Ltd (NATCOPHARM):企業の財務・戦略的SWOT分析
    Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Neuronetics Inc (STIM):医療機器:M&Aディール及び事業提携情報
    Summary Neuronetics Inc (Neuronetics) is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. The company provides neurostar TMS therapy system used to treat patients with depressive disorder. Its neurostar TMS components comprise practice data ma …
  • Saladax Biomedical Inc:企業の製品パイプライン分析
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • EMS SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EMS SA (EMS) is a pharmaceutical company, which is focused in the development of products for improvement of health and well-being of the population. It operates in prescription segments generics, branded pharmaceuticals, OTC and hospital. It has presence in the US market through Brace Pharm …
  • Ionian Hotel Enterprises S.A.:企業の戦略・SWOT・財務分析
    Ionian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report Summary Ionian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Valiant Holding AG:企業の戦略・SWOT・財務分析
    Valiant Holding AG - Strategy, SWOT and Corporate Finance Report Summary Valiant Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Indra Sistemas SA (IDR):企業の財務・戦略的SWOT分析
    Indra Sistemas SA (IDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Fuji Heavy Industries, Ltd.:戦略・SWOT・企業財務分析
    Fuji Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GS Engineering & Construction Corp (006360):企業の財務・戦略的SWOT分析
    GS Engineering & Construction Corp (006360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • B&M European Value Retail S.A.:戦略・SWOT・企業財務分析
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆